STING1 and cancer: Low STING expression on cancer cells was associated with shorter cancer-specific survival (CSS) in patients with CRC who received postoperative DNA-damaging chemotherapy or radiotherapy (Fig. 1C, log-rank p = 0.0479, n = 108).